News related to Clozaril (Clozapine) and/or conditions it is approved for
New Med Reduces Psychosis in Parkinson's Disease Patients
Source: MedPage Today Psychiatry [2015.06.19]
(MedPage Today) -- Pimavanserin appears safe across multiple phase III trials
Phase III data released for NUPLAZID (pimavanserin) for Parkinson's disease psychosis
Source: Clinical Trials / Drug Trials News From Medical News Today [2015.06.18]
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, have...
Perspective-taking difficulties diminished when autistic and psychosis tendencies balance
Source: Schizophrenia News From Medical News Today [2015.05.15]
Researchers at the University of Birmingham have shed new light on the relationship between autistic tendencies and psychosis proneness in neurotypical adults.
Source: MedicineNet Biorhythms Specialty [2015.05.14]
Title: ICU Psychosis
Category: Diseases and Conditions
Created: 12/10/1998 12:00:00 AM
Last Editorial Review: 5/14/2015 12:00:00 AM
Antipsychotic Use Increases Mortality in Parkinson's
Source: Medscape NeurologyHeadlines [2015.06.23]
Drugs to treat Parkinson's psychosis conferred excess mortality risk in the first 6 months, a study shows. Atypicals were safer than haloperidol but still conferred 2- to 3-fold excess mortality.
Medscape Medical News